Michael Patterson has been named the new president and CEO of Mississippi Valley Surgery Center in Davenport, Iowa, according to a Quad-City Times report.
Uncategorized
The following article is written by Robert Welti, MD, senior vice president of operations for Regent Surgical Health. The role of the medical director has become increasingly important over the past year. In addition to the usual three-year accreditation…
Medical director compensation can be a sticky subject for surgery centers, as physician responsibilities in a medical directorship role can vary tremendously between centers and compensation should only be tied to the duties of the role. Ben Ulrich, manager with…
Patients at dialysis treatment centers in Colorado suffered a total of 664 vascular access infections from April 2010-March 2011, amounting to an overall vascular access infection rate of 1.8 per 100 hemodialysis patients, according to the Colorado Department of Public…
Covidien, a surgical product and drug company, announced it will separate its pharmaceuticals division into a distinct company to focus on pain management, according to a Businessweek report.
Advertisement
Pain Specialists of Austin opened new treatment centers in Kyle and Killeen, Texas, according to a news release.
Scott Strassels, PharmD, PhD, BCPS, assistant professor of pharmacy, University of Texas at Austin, says community pharmacists can play an active role in the treatment of pain, according to a Modern Medicine report.
Researchers from Wayne State University, the Mayo Clinic and Johns Hopkins Medicine have discovered a way to treat macular degeneration and retinitis pigmentosa by attaching steroids to dendrimer nanoparticles and delivering the drug directly to the retina, according to a…
Daniel Carpenter, a professor of government at Harvard and the author of "Reputation and Power: Organizational Image and Pharmaceutical Regulation at the F.D.A.", says the decision by Health and Human Services secretary Kathleen Sebelius to block FDA approval of selling…
Bipartisan legislation that would require medical device manufacturers to track the performance of such products after they were approved for sale was introduced in the Senate yesterday, according to a New York Times report.